Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2002

01-07-2002 | Meeting abstract

Predicting breast cancer response to chemotherapy using quantitative magnetic resonance (MR) imaging

Authors: LW Turnbull, DJ Manton, M Lowry, A Maraveyas, A Chaturvedi, J Greenman, L Cawkwell, A Hubbard, A Modi, M Lind

Published in: Breast Cancer Research | Special Issue 1/2002

Login to get access

Excerpt

Change in tumour volume may be a relatively late manifestation of chemotherapy response in patients with inoperable breast cancer. Recent studies suggest that quantifying water apparent diffusion coefficient (ADC), microvessel permeability (Ktrans) or water to fat signal ratio (WFR), using magnetic resonance (MR) imaging or spectroscopy, may provide an early indication of ultimate treatment response. …
Metadata
Title
Predicting breast cancer response to chemotherapy using quantitative magnetic resonance (MR) imaging
Authors
LW Turnbull
DJ Manton
M Lowry
A Maraveyas
A Chaturvedi
J Greenman
L Cawkwell
A Hubbard
A Modi
M Lind
Publication date
01-07-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr479

Other articles of this Special Issue 1/2002

Breast Cancer Research 1/2002 Go to the issue

Meeting abstract

Evaluation of the need for magnification views in the assessment of calcification in computerised mammography

Meeting abstract

Assessing performance of screen readers in the National Health Service Breast Screening Programme (NHSBSP)

Meeting abstract

Our experience in using magnetic resonance imaging (MRI) as an adjunct to mammography and ultrasound in assessing response to neoadjuvant chemotherapy

Meeting abstract

Review of clinical trials

Meeting abstract

Technical recalls and technical repeats: evaluating the effect of the Occupational Standards/Skill Mix project

Meeting abstract

Pre-operative fine-needle aspiration cytology (FNAC) and core biopsy (CB) of radial scars (RS) and complex sclerosing lesions (CSL)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits